Journal of Cardiothoracic Surgery (Mar 2012)

Ondasetron versus haloperidol for the treatment of postcardiotomy delirium: a prospective, randomized, double-blinded study

  • Tagarakis Georgios I,
  • Voucharas Christos,
  • Tsolaki Fani,
  • Daskalopoulos Marios E,
  • Papaliagkas Vassilios,
  • Parisis Charalampos,
  • Gogaki Eleni,
  • Tsagalas Ιlias,
  • Sataitidis Ιlias,
  • Tsolaki Magda,
  • Tsilimingas Nikolaos B

DOI
https://doi.org/10.1186/1749-8090-7-25
Journal volume & issue
Vol. 7, no. 1
p. 25

Abstract

Read online

Abstract Background To investigate the controlling efficacy of ondasetron and haloperidol in regard to the postcardiotomy delirium. Methods We included in this prospective, randomized, double-blinded study 80 patients who developed delirium after heart surgery with the application of heart lung-machine. The patients were divided into two, equally-sized groups, which on detection of delirium received ondasetron 8 mg iv or haloperidol 5 mg iv respectively. The statistical analysis compared the baseline and demographic characteristics of the two groups (age, gender, comorbidities, years of education, type of surgery etc.). Results Both ondasetron and haloperidol had very good delirium controlling effects, without statistically significant differences. Discussion-Conclusions Ondasetron and haloperidol are efficient agents as far as the treatment of postcardiotomy delirium is concerned. As, in addition, ondasetron bares milder side-effects, we believe this could be the agent of choice in patients developing postcardiotomy delirium in the future.